Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Aurélie GoyenvalleK E Davies

Abstract

Duchenne muscular dystrophy (DMD) is a fatal muscle wasting disorder caused by mutations in the dystrophin gene. Antisense-mediated exon skipping is one of the most promising approaches for the treatment of DMD but still faces personalized medicine challenges as different mutations found in DMD patients require skipping of different exons. However, 70% of DMD patients harbor dystrophin gene deletions in a mutation-rich area or "hot-spot" in the central genomic region. In this study, we have developed 11 different U7 small-nuclear RNA, to shuttle antisense sequences designed to mask key elements involved in the splicing of exons 45 to 55. We demonstrate that these constructs induce efficient exon skipping both in vitro in DMD patients' myoblasts and in vivo in human DMD (hDMD) mice and that they can be combined into a single vector to achieve a multi skipping of at least 3 exons. These very encouraging results provide proof of principle that efficient multiexon-skipping can be achieved using adeno-associated viral (AAV) vectors encoding multiple U7 small-nuclear RNAs (U7snRNAs), offering therefore very promising tools for clinical treatment of DMD.

References

Nov 5, 1997·Nature Biotechnology·R ZuffereyD Trono
Nov 5, 1997·Genomics·C NobileG A Danieli
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·C J MannS D Wilton
Apr 2, 2003·Human Molecular Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
May 10, 2003·Cellular and Molecular Life Sciences : CMLS·C BrunJ Weis
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mattie Bremmer-BoutJudith C T van Deutekom
Nov 5, 2004·Cellular and Molecular Life Sciences : CMLS·D Schümperli, R S Pillai
Nov 6, 2004·Science·Aurélie GoyenvalleOlivier Danos
Dec 20, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Michael J BlankinshipJeffrey S Chamberlain
Dec 6, 2006·Annals of the New York Academy of Sciences·A Aartsma-RusJ C T Van Deutekom
Feb 8, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Steve D WiltonSusan Fletcher
Mar 21, 2007·Nature Medicine·Federico MingozziKatherine A High
Apr 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zejing WangRainer Storb
Jul 7, 2007·BMC Medical Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
Nov 6, 2007·Current Gene Therapy·Federico Mingozzi, Katherine A High
Dec 18, 2007·The Journal of Biological Chemistry·Peter A C 't HoenJohan T den Dunnen
Dec 28, 2007·The New England Journal of Medicine·Judith C van DeutekomGert-Jan B van Ommen
Oct 2, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yongping YueDongsheng Duan
Nov 18, 2008·Muscle & Nerve·Verónica FerreiroIrene Szijan
Dec 3, 2008·BMC Medical Genetics·Laura van VlietAnnemieke Aartsma-Rus
Jan 22, 2009·Human Mutation·Annemieke Aartsma-RusJohan T den Dunnen
Mar 17, 2009·Biochimica Et Biophysica Acta·Chris RuszczakNick Menhart
Mar 17, 2009·Annals of Neurology·Toshifumi YokotaEric Hoffman
May 21, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Aurélie GoyenvalleKay E Davies
Dec 31, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zejing WangStephen J Tapscott
May 12, 2010·Laboratory Investigation; a Journal of Technical Methods and Pathology·Pietro SpitaliAnnemieke Aartsma-Rus
Oct 12, 2010·The New England Journal of Medicine·Jerry R MendellChristopher M Walker
Mar 25, 2011·The New England Journal of Medicine·Nathalie M GoemansJudith C van Deutekom
May 12, 2011·Human Molecular Genetics·Davin M HendersonJames M Ervasti
Jul 30, 2011·Skeletal Muscle·Aurélie Goyenvalle, Kay E Davies

❮ Previous
Next ❯

Citations

May 30, 2013·EMBO Molecular Medicine·Christina Gedicke-HornungLucie Carrier
Jun 12, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maëva Le HirStéphanie Lorain
Jun 1, 2012·Human Gene Therapy·Helen FosterGeorge Dickson
Mar 26, 2013·Human Gene Therapy·Taeyoung Koo, Matthew J Wood
Sep 10, 2014·Nature Medicine·Shireen R Lamandé, Kathryn N North
Feb 8, 2013·The FEBS Journal·Sara BenedettiFrancesco Saverio Tedesco
Jan 23, 2015·Annals of Neurology·Andrew R FindlayUNKNOWN United Dystrophinopathy Project
Aug 22, 2014·Pathology International·Eun-Joo LeeKyu-Shik Jeong
May 2, 2013·Molecular and Cellular Neurosciences·Andrew G L Douglas, Matthew J A Wood
May 2, 2014·Frontiers in Physiology·Emanuele BerardiMaurilio Sampaolesi
Jan 31, 2017·Genes·Marine ImbertAurélie Goyenvalle
Mar 2, 2017·Genes·Marc Suñé-PouCarlos Suñé
May 18, 2018·Human Molecular Genetics·Lucía EchevarríaAurélie Goyenvalle
Jan 20, 2018·The International Journal of Neuroscience·Arash SalmaninejadMajid Mojarrad
Jun 2, 2012·Expert Opinion on Biological Therapy·Toshifumi YokotaHanna Kolski
Sep 2, 2015·Journal of Neuromuscular Diseases·Florian BarthélémyMarc Bartoli
Apr 4, 2020·The International Journal of Neuroscience·Arash SalmaninejadMajid Mojarrad
Nov 18, 2016·Journal of Neuromuscular Diseases·Merryl RodriguesToshifumi Yokota
Aug 16, 2012·Current Opinion in Neurology·Ingrid E C Verhaart, Annemieke Aartsma-Rus
Sep 29, 2020·Biologics : Targets & Therapy·Annette d'Arqom
May 29, 2020·Molecular Therapy. Methods & Clinical Development·Philippine AupyAurélie Goyenvalle
Jun 19, 2021·Human Gene Therapy·Daniel LesmanNicolas Wein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Aurélie GoyenvalleK E Davies
Experimental Cell Research
Yuko Miyagoe-Suzuki, Shin'ichi Takeda
Molecular Therapy : the Journal of the American Society of Gene Therapy
Adeline VulinLuis Garcia
© 2022 Meta ULC. All rights reserved